Editorial Review for: Why Is There Low Utilization of Biosimilars in Inflammatory Bowel Disease Patients by Gastroenterology Advanced Practice Providers?

Detalles Bibliográficos
Autor principal: Hanson, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802059/
https://www.ncbi.nlm.nih.gov/pubmed/36777268
http://dx.doi.org/10.1093/crocol/otab005
_version_ 1784861612265439232
author Hanson, Karen
author_facet Hanson, Karen
author_sort Hanson, Karen
collection PubMed
description
format Online
Article
Text
id pubmed-9802059
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-98020592023-02-10 Editorial Review for: Why Is There Low Utilization of Biosimilars in Inflammatory Bowel Disease Patients by Gastroenterology Advanced Practice Providers? Hanson, Karen Crohns Colitis 360 Editorials Oxford University Press 2021-04-02 /pmc/articles/PMC9802059/ /pubmed/36777268 http://dx.doi.org/10.1093/crocol/otab005 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorials
Hanson, Karen
Editorial Review for: Why Is There Low Utilization of Biosimilars in Inflammatory Bowel Disease Patients by Gastroenterology Advanced Practice Providers?
title Editorial Review for: Why Is There Low Utilization of Biosimilars in Inflammatory Bowel Disease Patients by Gastroenterology Advanced Practice Providers?
title_full Editorial Review for: Why Is There Low Utilization of Biosimilars in Inflammatory Bowel Disease Patients by Gastroenterology Advanced Practice Providers?
title_fullStr Editorial Review for: Why Is There Low Utilization of Biosimilars in Inflammatory Bowel Disease Patients by Gastroenterology Advanced Practice Providers?
title_full_unstemmed Editorial Review for: Why Is There Low Utilization of Biosimilars in Inflammatory Bowel Disease Patients by Gastroenterology Advanced Practice Providers?
title_short Editorial Review for: Why Is There Low Utilization of Biosimilars in Inflammatory Bowel Disease Patients by Gastroenterology Advanced Practice Providers?
title_sort editorial review for: why is there low utilization of biosimilars in inflammatory bowel disease patients by gastroenterology advanced practice providers?
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802059/
https://www.ncbi.nlm.nih.gov/pubmed/36777268
http://dx.doi.org/10.1093/crocol/otab005
work_keys_str_mv AT hansonkaren editorialreviewforwhyistherelowutilizationofbiosimilarsininflammatoryboweldiseasepatientsbygastroenterologyadvancedpracticeproviders

Ejemplares similares